Takara Bio USA and SPT Labtech has announced their partnership to deliver automated library preparation workflows that combine Takara Bio next-gen sequencing library preparation chemistries with SPT Labtech’s firefly liquid handling platform.
Recipharm, a global CDMO, has announced that it has extended its high potency offering at its Leganés site in Spain to GMP pilot scale, giving customers a single high containment route from development to commercial supply.
A UK start-up, whose powder transfer valve "solves some of the key challenges facing pharmaceutical manufacturers", has raised over £2.4m to commercialise its technology.
IQVIA and Veeva Systems has announced an expansion of their partnership with the selection of Veeva CTMS, eTMF, Study Startup, and Site Connect as enterprise standard applications that will be used across IQVIA clinical development studies.
Lonza and Qurient, a clinical-stage biopharmaceutical company, has announced an exclusive license agreement for the use of Qurient’s cyclin-dependent kinase 7 (CDK7) inhibitors for dual-payload antibody-drug conjugate (ADC) applications.
Bespak has announced the signing of a Memorandum of Understanding (MOU) with Shin Nippon Biomedical Laboratories (SNBL) under which Bespak will offer immediate and exclusive global access to SNBL's proprietary nasal dry powder delivery device.
Sterling Pharma Solutions has announced completion of an additional, large-scale GMP manufacturing suite at its dedicated bioconjugation facility in the UK, which will double capacity, as well as increasing the scale of manufacturing to 500L.
SPI Pharma and Colorcon have announced a strategic global partnership to accelerate the growth and adoption of oral solid dose product solutions across the pharmaceutical industry.
Ensera has launched the Ensera Alliance Network, bringing together device platform and fill-finish specialists to address the complexity of commercialising drug-device combination products.
Ross Turnbull, director of business development at ASIC design and supply specialist Swindon Silicon Systems, explains why the silicon behind sensors matters as much as the investment itself.
